0 followers
Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.
Bristol-Myers Squibb
210 followers
Astellas Pharma
33 followers
Syneos Health
23 followers
Alnylam Pharmaceuticals
23 followers
Catalent
21 followers
Prescient Healthcare Group
26 followers
Omnicell
21 followers
Organon
17 followers
NYU Langone Health
16 followers
Parexel
9 followers
PCI Pharma Services
7 followers
Explore companies